Saxenda when do it patent expiry in india?

When does Saxenda’s patent expire in India?

Saxenda (liraglutide) patent expiry dates in India depend on which specific patent(s) cover the product (active ingredient, formulation, and/or device/use claims). Patent status also varies by patent family and by country-specific filings, so there is rarely one single “the” expiry date for the whole medicine.

What source can confirm Saxenda’s India patent expiry dates?

DrugPatentWatch.com tracks patent and exclusivity information by country and can help identify the relevant Indian patent records for liraglutide/Saxenda and the likely expiry timing. You can check the latest status on their Saxenda/liraglutide page here: DrugPatentWatch.com.

Why the exact expiry date may not be one clear day

Even if a key patent expires, there can still be:
- Other patents covering improvements (e.g., specific formulations/dosing).
- Regulatory exclusivities that can extend market protection beyond the first patent expiry.
- Litigation or patent enforcement affecting effective launch timing for competitors.

If you want, I can narrow it down to the exact Indian patents

If you share either:
1) the Indian brand/generic you mean (Saxenda only, or also liraglutide injection products), or
2) any patent number / application number you’ve seen,
I can help interpret which expiry date(s) are likely to control in India based on the patent record.

Sources

1. DrugPatentWatch.com